This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1997 Jun 5;336(23):1674; author reply 1675.

doi: 10.1056/NEJM199706053362311.

Treatment of ovarian cancer with intraperitoneal cisplatin

M Beltran, R Fuentes, A Izquierdo

PMID: 9173271
DOI: 10.1056/NEJM199706053362311

Comment

Treatment of ovarian cancer with intraperitoneal cisplatin

M Beltran et al. N Engl J Med. 1997.

. 1997 Jun 5;336(23):1674; author reply 1675.

doi: 10.1056/NEJM199706053362311.

Authors

M Beltran, R Fuentes, A Izquierdo

PMID: 9173271
DOI: 10.1056/NEJM199706053362311

No abstract available

PubMed Disclaimer

Comment on

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.
Alberts DS, Liu PY, Hannigan EV, O'Toole R, Williams SD, Young JA, Franklin EW, Clarke-Pearson DL, Malviya VK, DuBeshter B. Alberts DS, et al. N Engl J Med. 1996 Dec 26;335(26):1950-5. doi: 10.1056/NEJM199612263352603. N Engl J Med. 1996. PMID: 8960474 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information